(ALLO) Allogene Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Allogene Therapeutics | (ALLO) share price targets
Complete technical analysis of Allogene Therapeutics (ALLO) by charts plus indicators, forecast predictions and share price targets for Allogene Therapeutics (ALLO)
Allogene Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-07 View latest technical analysis
10 day averaged volume of Allogene Therapeutics is 1700595
Date | Daily Closing Price | Open | High | Low | Volume |
07 Wed Aug 2024 | 2.47 | 2.61 | 2.71 | 2.41 | 1.432 times |
06 Tue Aug 2024 | 2.55 | 2.51 | 2.60 | 2.37 | 0.994 times |
05 Mon Aug 2024 | 2.49 | 2.40 | 2.54 | 2.32 | 1.378 times |
02 Fri Aug 2024 | 2.57 | 2.50 | 2.60 | 2.47 | 0.986 times |
01 Thu Aug 2024 | 2.74 | 2.95 | 2.97 | 2.69 | 0.904 times |
31 Wed Jul 2024 | 2.94 | 3.00 | 3.09 | 2.86 | 1.199 times |
30 Tue Jul 2024 | 2.97 | 2.97 | 3.06 | 2.86 | 0.716 times |
29 Mon Jul 2024 | 2.98 | 2.99 | 3.12 | 2.94 | 0.863 times |
26 Fri Jul 2024 | 3.00 | 2.99 | 3.05 | 2.86 | 0.938 times |
25 Thu Jul 2024 | 2.91 | 2.91 | 2.99 | 2.85 | 1.067 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.6, but if it comes above 2.6, then a intra day buy could be more profitable.
If you take a sell trade below 2.6, then use 2.6 as stoploss and 2.3 as target. However if you take a buy trade in stock , then use 2.6 as stoploss and 2.89 as target.
Share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Target | 2.01 |
Downside Target | 2.13 |
Downside Target | 2.18 |
Downside Target | 2.31 |
Downside Target | 2.47 |
Upside Target | 2.68 |
Upside Target | 2.85 |
Upside Target | 2.97 |
Upside Target | 3.12 |
Upside Target | 3.65 |
Upside Target | 3.67 |
Upside Target | 4.45 |
Intraday share price targets for Allogene Therapeutics (ALLO)
Target Type | Value |
Downside Intraday Target | 2.29 |
Downside Intraday Target | 2.11 |
Upside Intraday Target | 2.68 |
Upside Intraday Target | 2.89 |
Upside Intraday Target | 2.5 |
Weekly technical analysis of Allogene Therapeutics (ALLO)
Date | Weekly Closing Price | Open | High | Low | Volume |
07 Wed Aug 2024 | 2.47 | 2.40 | 2.71 | 2.32 | 0.815 times |
02 Fri Aug 2024 | 2.57 | 2.99 | 3.12 | 2.47 | 0.858 times |
26 Fri Jul 2024 | 3.00 | 2.85 | 3.12 | 2.73 | 0.392 times |
19 Fri Jul 2024 | 2.83 | 2.78 | 3.67 | 2.74 | 2.111 times |
12 Fri Jul 2024 | 2.76 | 2.19 | 2.85 | 2.13 | 2.742 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Allogene Therapeutics (ALLO)
Date | Monthly Closing Price | Open | High | Low | Volume |
07 Wed Aug 2024 | 2.47 | 2.95 | 2.97 | 2.32 | 0.162 times |
31 Wed Jul 2024 | 2.94 | 2.33 | 3.67 | 2.01 | 0.887 times |
28 Fri Jun 2024 | 2.33 | 2.53 | 2.68 | 2.18 | 1.161 times |
31 Fri May 2024 | 2.50 | 2.78 | 3.65 | 2.31 | 1.407 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Allogene Therapeutics (ALLO)
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Allogene Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.74 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Allogene Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Allogene Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.74 and Allogene Therapeutics (ALLO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.